Eastern Mediterranean (WHO region) vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB

Eastern Mediterranean (WHO region)
75.0%
in 2022
United Arab Emirates
100.0%
in 2022
Eastern Mediterranean (WHO region) rank
4th
United Arab Emirates rank
1st

Treatment success rate for patients treated for MDR-TB over time

  • Eastern Mediterranean (WHO region)
  • United Arab Emirates
020406080100200220122022

How they compare

United Arab Emirates currently reports 100.0% against 75.0% in Eastern Mediterranean (WHO region), a difference of 25.0%.

That makes United Arab Emirates's figure about 1.3 times Eastern Mediterranean (WHO region)'s.

The two have swapped places 2 times across 9 shared years of data; in 2007 it was United Arab Emirates ahead.

Eastern Mediterranean (WHO region) ranks 4th and United Arab Emirates ranks 1st of 11 groups.

Across the 3 decades both report, Eastern Mediterranean (WHO region) averaged higher in 1 and United Arab Emirates in 2.

Head to head by decade

Decade Eastern Mediterranean (WHO region) United Arab Emirates Difference Ahead
2000s 50.5% 100.0% 49.5% United Arab Emirates
2010s 66.7% 25.0% 41.7% Eastern Mediterranean (WHO region)
2020s 75.0% 100.0% 25.0% United Arab Emirates

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate for patients treated for mdr-tb, Eastern Mediterranean (WHO region) or United Arab Emirates?
United Arab Emirates, at 100.0% against 75.0% in Eastern Mediterranean (WHO region) as of 2022.
What is the difference in treatment success rate for patients treated for mdr-tb between Eastern Mediterranean (WHO region) and United Arab Emirates?
25.0%, with United Arab Emirates ahead.
How many years of comparable data are there for Eastern Mediterranean (WHO region) and United Arab Emirates?
9 years are reported by both, from 2007 to 2022.
How do Eastern Mediterranean (WHO region) and United Arab Emirates rank globally for treatment success rate for patients treated for mdr-tb?
Eastern Mediterranean (WHO region) ranks 4th and United Arab Emirates ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Eastern Mediterranean (WHO region) vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/eastern-mediterranean-who-region/united-arab-emirates/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/eastern-mediterranean-who-region/united-arab-emirates/">Eastern Mediterranean (WHO region) vs United Arab Emirates: Treatment success rate for patients treated for MDR-TB</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed